Science Explorer Interactive view Map
Company · Zurich · Switzerland

Novo Nordisk (Switzerland)

novonordisk.comROR OpenAlex
World rank, all time
#36,594
of 42,892
Rank in Switzerland
#377
of 429
Research works
152
▲ 51% vs 2013–17
Citations
2.4k
15.6 per fractional work
Top-10% rate
14.0%
record average 16.5%
Open access
54%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.32× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 1.22× its world share, 0 worksImmunology and Micro…Neuroscience: 1.14× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.27× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.93× its world share, 0 worksChemical EngineeringChemistry: 1.38× its world share, 1 worksChemistryComputer Science: 0.01× its world share, 0 worksComputer ScienceEngineering: 0.20× its world share, 1 worksEngineeringEnvironmental Science: 0.64× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.14× its world share, 0 worksMaterials ScienceMathematics: 0.90× its world share, 0 worksMathematicsDentistry: 0.41× its world share, 0 worksDentistryHealth Professions: 0.84× its world share, 1 worksHealth ProfessionsMedicine: 3.16× its world share, 23 worksMedicineNursing: 4.10× its world share, 1 worksNursingArts and Humanities: 0.04× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.51× its world share, 1 worksBusiness, Management…Decision Sciences: 0.11× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.48× its world share, 1 worksEconomics, Econometr…Psychology: 0.07× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.3×. Every wedge is a field page.

Who are the top researchers at Novo Nordisk (Switzerland)?

Ranked on the composite score, Eilon D. Kirson lead among researchers whose main affiliation is Novo Nordisk (Switzerland).

  1. 1 Eilon D. Kirson Switzerland · #182,607 worldwide 194 citations · 26 works
All ranked researchers at Novo Nordisk (Switzerland)

Which keywords describe research at Novo Nordisk (Switzerland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Gene Therapy, Prophylaxis, Immunotherapy, Glycemic Control, Factor VIII, Hemophilia, Insulin Therapy and Obesity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Gene Therapy3▲ 41×4 topics
  2. Epidemiology3▲ 1.82×13 topics
  3. Cardiovascular Disease3▲ 6.0×13 topics
  4. Factor VIII3▲ 464×1 topic
  5. Glycemic Control3▲ 43×4 topics
  6. Hemophilia3▲ 464×1 topic
  7. Immunotherapy3▲ 9.4×6 topics
  8. Prophylaxis3▲ 53×2 topics
  9. Insulin Therapy2▲ 54×3 topics
  10. Obesity2▲ 8.5×12 topics
  11. Type 2 Diabetes2▲ 29×3 topics
  12. Heart Failure2▲ 13×7 topics
  13. Radiotherapy2▲ 15×2 topics
  14. Glioblastoma2▲ 79×1 topic
  15. Temozolomide2▲ 79×1 topic
  16. Diabetes2▲ 10×5 topics
  17. Inflammation2▲ 2.5×15 topics
  18. Clinical Guidelines2▲ 17×3 topics
  19. Sickle-cell Disease2▲ 115×1 topic
  20. Thalassemia2▲ 115×1 topic
  21. Cancer2▲ 3.5×12 topics
  22. Cardiovascular Outcomes2▲ 81×1 topic
  23. Glucose Control2▲ 81×1 topic
  24. Metabolic Syndrome2▲ 5.4×11 topics
  25. Anemia1▲ 37×3 topics
  26. Monoclonal Antibodies1▲ 42×3 topics
  27. Insulin Resistance1▲ 7.4×6 topics
  28. Oxidative Stress1▲ 2.1×3 topics
  29. Therapeutic Antibodies1▲ 47×2 topics
  30. Quality of Life1▲ 2.1×4 topics
  31. Environmental Impact1▲ 1.70×2 topics
  32. Life Cycle Assessment1▲ 10×2 topics
  33. Lifestyle Intervention1▲ 35×2 topics
  34. Metabolism1▲ 5.2×4 topics
  35. Solvent Selection1▲ 131×1 topic
  36. Sustainable Chemistry1▲ 131×1 topic

Which research topics does Novo Nordisk (Switzerland) publish most on?

By volume in 2022–2025: Hemophilia Treatment and Research, Glioma Diagnosis and Treatment, Hemoglobinopathies and Related Disorders and Diabetes Treatment and Management.

Hemophilia Treatment and Research: 3 fractional worksGlioma Diagnosis and Treatment: 2 fractional worksHemoglobinopathies and Related Disorders: 2 fractional worksDiabetes Treatment and Management: 2 fractional worksChemistry and Chemical Engineering: 1 fractional worksHealth Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksGrowth Hormone and Insulin-like Growth Factors: 1 fractional worksProtein purification and stability: 1 fractional worksDiabetes Management and Research: 1 fractional worksBlood groups and transfusion: 1 fractional works
HematologyGeneticsEndocrinology, Diabetes and MetabolismEnvironmental Chemistry2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hemophilia Treatment and Research Hematology 3 works
  2. 2 Glioma Diagnosis and Treatment Genetics 2 works
  3. 3 Hemoglobinopathies and Related Disorders Genetics 2 works
  4. 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
  5. 5 Chemistry and Chemical Engineering Environmental Chemistry 1 works
  6. 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  7. 7 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Protein purification and stability Molecular Biology 1 works
  9. 9 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  10. 10 Blood groups and transfusion Hematology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.5%not open46.5%

World: 28% of research is openly available.

with international co-authors71.3%domestic only28.7%

World: 19% is written across borders.

How has Novo Nordisk (Switzerland)'s research output changed?

Output in 2018–2022 was 51% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Zurich

All research institutions in Zurich

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.